Methodological Concerns Regarding the Causal Relationship Between Methotrexate and COPD: The Missing Confounding by Indication [Letter]
International Journal of Chronic Obstructive Pulmonary Disease · 2026-08 · Volume 21 · 1-3
DOI: 10.2147/copd.s640052 ↗Kurz gefasst
Leserbrief in der Zeitschrift International Journal of Chronic Obstructive Pulmonary Disease, 2026-08. Verfasst von Qingqing Shan. Beteiligte Einrichtung: Department of Respiration, Chengdu Integrated TCM & Western Medicine Hospital, Chengdu, 610095, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Themen: COPD
Abstract (Originalsprache)
Obstructive Pulmonary Disease: A Study Based on Network Toxicology and Mendelian Randomization". 1 The authors used an innovative dual-method framework merging network toxicology and Mendelian randomization (MR) to examine whether methotrexate (MTX) use increases the risk of developing chronic obstructive pulmonary disease (COPD).While we commend the authors for their new methodological approach and the combination of molecular docking with genetic epidemiology, we wish to raise a critical methodological concern that may substantially affect the interpretation of their findings-specifically, the failure to adequately address confounding by indication arising from rheumatoid arthritis (RA) itself.2,3 RA as an Independent Risk Factor for COPDThe authors appropriately note in their introduction that "RA patients using MTX have a higher risk of developing COPD than the general population".However, this observation shows a well-established epidemiological fact: RA itself is an independent risk factor for COPD, irrespective of MTX exposure.4 A recent systematic review and meta-analysis of 19 studies comprising 1,549,181 participants showed a significant bidirectional association between RA and COPD, with RA increasing COPD risk by 41% (OR = 1.41, 95% CI: 1.13-1.76,P = 0.003).4 A large-scale real-world cohort study from the TriNetX Research Network involving 136,820 propensity-matched pairs found that the 5-year cumulative probability of COPD was 7.36% in RA patients versus 5.97% in non-RA individuals (HR = 1.228, 95% CI: 1.186-1.272).5 Subgroup analyses, moreover, revealed that male RA patients faced even higher risk (HR = 1.300), and patients under 60 years of age had the most pronounced risk elevation (HR = 1.560).5 Analysis of NHANES 2007-2020 data (25,682 participants) confirmed that RA remained significantly associated with COPD even after comprehensive adjustment for demographic, socioeconomic, lifestyle, and health-related factors (adjusted OR = 1.52, 95% CI: 1.23-1.87,P < 0.001).6 Moreover, a bidirectional association exists: COPD itself may also increase RA risk.MR analysis has shown a causal relationship between COPD and increased odds of RA (OR = 1.072,P = 0.008).4 This bidirectional association underscores shared pathogenic mechanisms, including systemic inflammation, common genetic susceptibility, and the "lung-joint axis" hypothesis, in which citrullinated protein antibodies may initially form in the pulmonary mucosa before migrating to the synovium.4 The Core Issue: Confounding by IndicationThe main challenge in the authors' MR analysis is the inability to separate MTX effects from those of underlying RA.2,3 This represents a standard case of confounding by indication-a bias that occurs when the indication for drug
Autor:innen und Institutionen
- Department of Respiration, Chengdu Integrated TCM & Western Medicine Hospital, Chengdu, 610095, People's Republic of China.
ORCID-Profile: Qingqing Shan
Zitieren
APA
Shan, Q. (2026). Methodological Concerns Regarding the Causal Relationship Between Methotrexate and COPD: The Missing Confounding by Indication [Letter]. International Journal of Chronic Obstructive Pulmonary Disease, Volume 21, 1-3. https://doi.org/10.2147/copd.s640052
Vancouver
Shan Q. Methodological Concerns Regarding the Causal Relationship Between Methotrexate and COPD: The Missing Confounding by Indication [Letter]. International Journal of Chronic Obstructive Pulmonary Disease. 2026;Volume 21:1-3. doi:10.2147/copd.s640052
BibTeX
@article{Shan2026,
author = {Shan, Qingqing},
title = {Methodological Concerns Regarding the Causal Relationship Between Methotrexate and COPD: The Missing Confounding by Indication [Letter]},
journal = {International Journal of Chronic Obstructive Pulmonary Disease},
year = {2026},
volume = {Volume 21},
pages = {1--3},
doi = {10.2147/copd.s640052}
}
EUVIMED